Genistein protects dopaminergic neurons by inhibiting microglial activation

Neuroreport. 2005 Feb 28;16(3):267-70. doi: 10.1097/00001756-200502280-00013.

Abstract

Inflammation participates in the pathogenesis and progression of Parkinson's disease, in which microglia play a key role. Inhibition of microglia activation has been shown to attenuate inflammation-mediated dopaminergic neurodegeneration. In this study, we found that genistein, the primary soybean isoflavone, concentration-dependently attenuated the lipopolysaccharide-induced decrease in dopamine uptake and loss of tyrosine hydroxylase-immunoreactive neurons in rat mesencephalic neuron-glia cultures. Genistein also inhibited lipopolysaccharide-induced microglia activation and production of tumor necrosis factor-alpha, nitric oxide and superoxide in mesencephalic neuron-glia cultures and microglia-enriched cultures. Our results indicate that genistein may protect dopaminergic neurons from lipopolysaccharide-induced injury and its effective inhibition of microglia activation may be one of the mechanisms.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD11b Antigen / metabolism
  • Cells, Cultured
  • Coculture Techniques
  • Dopamine / metabolism*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Embryo, Mammalian
  • Enzyme Inhibitors / pharmacology
  • Genistein / pharmacology*
  • Immunohistochemistry / methods
  • Lipopolysaccharides / pharmacology
  • Mesencephalon / cytology*
  • Microglia / drug effects*
  • Neurons / drug effects
  • Neurons / metabolism*
  • Rats
  • Tritium / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • CD11b Antigen
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Tritium
  • Genistein
  • Dopamine